Financial Performance - Q4 2023 - Mettler-Toledo's Q4 net sales decreased by 12% to $934.992 million[25], with a local currency sales decline of 13%[3, 25] - The adjusted operating margin for Q4 was 30.1%, a decrease of 380 basis points[3, 25] - Adjusted EPS for Q4 was $9.40, a decrease of 22%[3, 25] Financial Performance - Full Year 2023 - Full year net sales decreased by 3% to $3.788 billion[5, 26], with a local currency sales decline of 3%[5, 26] - The adjusted operating margin for the full year was 30.4%[26] - Adjusted EPS for the full year was $38.03, a decrease of 4%[26] Sales by Geography - Q4 2023 - Americas sales increased by 9% in local currency to $428 million[4] - Europe sales decreased by 16% in local currency to $260 million[4] - Asia/ROW sales decreased by 18% in local currency to $273 million[4] Sales by Geography - Full Year 2023 - Americas sales decreased by 1% in local currency to $1.568 billion[5] - Europe sales decreased by 2% in local currency to $1.015 billion[5] - Asia/ROW sales decreased by 5% in local currency to $1.205 billion[5] Sales by Product - Q4 2023 - Laboratory sales decreased by 18% in local currency to $513 million[7] - Industrial sales decreased by 7% in local currency to $370 million[7] - Food sales increased by 9% in local currency to $51 million[7] Sales by Product - Full Year 2023 - Laboratory sales decreased by 7% in local currency to $2.069 billion[10] - Industrial sales decreased by 1% in local currency to $1.490 billion[10] - Food sales increased by 27% in local currency to $229 million[10]

Financial Performance - Net sales for Q3 2023 were $942.5 million, a decrease of 4% compared to $985.8 million in Q3 2022, while net sales for the nine months ended September 30, 2023 remained flat at $2.9 billion compared to the same period in 2022[97]. - Gross profit margin for Q3 2023 was 59.4%, slightly up from 59.3% in Q3 2022, and for the nine months ended September 30, 2023, it was 59.2%, compared to 58.6% in the same period of 2022[105]. - Total net sales in U.S. operations decreased by 5% to $388,011 thousand for the three months ended September 30, 2023, and by 2% to $1,151,517 thousand for the nine months ended September 30, 2023 compared to 2022[115]. - Total net sales in Swiss operations were flat in U.S. dollars for the three months ended September 30, 2023, while net sales to external customers increased by 23%[117]. - Total net sales in Chinese operations decreased by 25% to $232,404 thousand for the three months ended September 30, 2023, and by 12% to $767,572 thousand for the nine months ended September 30, 2023 compared to 2022[123]. - Total net sales in other operations increased by 12% to $180,616 thousand for the three months ended September 30, 2023, and by 10% to $517,406 thousand for the nine months ended September 30, 2023 compared to 2022[126]. Expenses and Costs - Research and development expenses increased by 5% in U.S. dollars for Q3 2023, totaling $46.1 million, and were 4.9% of net sales, compared to 4.5% in Q3 2022[107]. - Selling, general and administrative expenses decreased by 7% in U.S. dollars for Q3 2023, amounting to $217.4 million, and represented 23.1% of net sales, down from 23.7% in Q3 2022[108]. - Interest expense rose to $20.3 million in Q3 2023 from $14.5 million in Q3 2022, reflecting higher variable interest rates[110]. - Restructuring charges increased to $7.4 million in Q3 2023 from $2.0 million in Q3 2022, primarily due to employee-related costs[111]. Market Conditions - The company expects reduced sales in China for the remainder of 2023 due to significantly deteriorating market demand[98]. - Net sales of laboratory-related products, which accounted for approximately 55% of total net sales, decreased by 8% in U.S. dollars for Q3 2023[102]. - Net sales of industrial-related products decreased by 5% in U.S. dollars for Q3 2023, while service revenue increased by 9% in U.S. dollars for the same period[101]. Tax and Profitability - The reported tax rate for Q3 2023 was 19.7%, slightly down from 20.0% in Q3 2022[113]. - Segment profit in U.S. operations decreased by $3.2 million for the three months but increased by $14.8 million for the nine months ended September 30, 2023, due to margin expansion and cost savings initiatives[116]. - Segment profit in Chinese operations decreased by $39.5 million for the three months and by $28.9 million for the nine months ended September 30, 2023, primarily due to lower sales volume and unfavorable currency translation[125]. Cash Flow and Capital Expenditures - Cash provided by operating activities totaled $684.4 million during the nine months ended September 30, 2023, an increase from $555.4 million in the corresponding period in 2022[131]. - Capital expenditures totaled $72.9 million for the nine months ended September 30, 2023, down from $89.2 million in the corresponding period in 2022[132]. Debt and Financing - As of September 30, 2023, total debt amounted to $2.108 billion, with long-term debt at $1.929 billion[137]. - The company has $545.2 million of additional borrowings available under its Credit Agreement and $69.7 million in cash and cash equivalents[138]. - The company issued $150 million in 5.45% Senior Notes in March 2023, maturing in March 2033, to refinance existing indebtedness[141]. - The company amended its Credit Agreement in May 2023 to replace LIBOR with SOFR as the interest rate benchmark[139]. - The company was in compliance with its debt covenants as of September 30, 2023[140]. Share Repurchase Program - The company has $2.7 billion remaining for its share repurchase program as of September 30, 2023, having repurchased 31.5 million shares since the program's inception in 2004[144][145]. - During the nine months ended September 30, 2023, the company spent $724 million on share repurchases at an average price of $1,388.54 per share[145]. Currency Impact - A 1% strengthening of the Swiss franc against the euro is estimated to reduce earnings before tax by approximately $2.0 million to $2.3 million annually[147]. - A 1% weakening of the Chinese renminbi against the U.S. dollar is estimated to reduce earnings before tax by approximately $3.3 million to $3.6 million annually[148]. - A 5% weakening of the U.S. dollar against the currencies in which the company's debt is denominated would increase the reported U.S. dollar value of debt by approximately $34.1 million[149].

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (State or other jurisdiction of (I.R.S Employer Identification No.) incorporation or organization) 1900 Polaris Parkway Columbus, OH 43240 and Im Langacher, P.O. Box MT-100 CH 8606 Greifensee, Switzerland 1-614-438-4511 and +41-44-944-22-11 ________________________________________________________________________________ (Registrant's telephone number, including area code) not applicable ______________________ ...

Local currency sales + 2% Adjusted Operating Profit Adjusted EPS Sales by Geography Note: Local currency (LC) sales excludes foreign exchange impact. Sales by Product Area 6 Q2 Local Currency Sales Growth Lab (54% of total sales) Industrial (40%) Food Retail (6%) Total (100%) 13% 9% 3% 10% -3% 6% 17% 2% 2022 2023 Note: Local currency (LC) sales excludes foreign exchange impact. Sales by Product Area 7 YTD Local Currency Sales Growth Lab (55% of total sales) Industrial (39%) Food Retail (6%) Total (100%) 15% ...

Mettler-Toledo International Inc. (NYSE:MTD) Q2 2023 Earnings Conference Call July 27, 2023 4:30 PM ET Company Participants Adam Uhlman - Head-Investor Relations Patrick Kaltenbach - Chief Executive Officer Shawn Vadala - Chief Financial Officer Conference Call Participants Daniel Arias - Stifel Jack Meehan - Nephron Research Derik de Bruin - Bank of America Patrick Donnelly - Citigroup Vijay Kumar - Evercore Matthew Sykes - Goldman Sachs Catherine Schulte - Baird Joshua Waldman - Cleveland Research Rachel ...

Financial Performance - Net sales for the three months ended March 31, 2023, were $928.7 million, a 3% increase from $897.8 million in the same period of 2022, with a 7% increase in local currencies[91] - Net earnings for the three months ended March 31, 2023, were $188.4 million, up from $174.0 million in the same period of 2022, reflecting a net earnings margin of 20.3%[90] - Total net sales decreased by 6% in U.S. dollars but increased by 1% in local currency for the three months ended March 31, 2023, compared to the same period in 2022[117] - Net sales in the Americas increased by 5%, while Europe and Asia/Rest of World saw a 2% increase in U.S. dollars for the three months ended March 31, 2023[93] - Net sales of food retailing products surged by 32% in U.S. dollars and 36% in local currencies during the three months ended March 31, 2023[98] - Net sales to external customers increased by 4% in U.S. dollars and 9% in local currencies during the same period, driven by strong growth in laboratory products[119] Profitability - Gross profit margin improved to 58.9% for the three months ended March 31, 2023, compared to 57.9% in the same period of 2022, driven by favorable price realization[99][100] - Segment profit for U.S. Operations increased by 9% to $81.8 million for the three months ended March 31, 2023, supported by margin expansion initiatives[108] - Segment profit for Swiss Operations rose by 7% to $76.4 million, with strong growth in food retailing and industrial sectors[111] - Segment profit increased by $3.8 million for the three months ended March 31, 2023, primarily due to margin expansion initiatives and increased sales volume[120] Expenses - Research and development expenses increased by 6% in U.S. dollars and 9% in local currencies, representing 4.9% of net sales for the three months ended March 31, 2023[101] - Selling, general and administrative expenses were flat in U.S. dollars and increased by 2% in local currencies, accounting for 25.3% of net sales for the three months ended March 31, 2023[102] Cash Flow and Capital Expenditures - Cash provided by operating activities totaled $153.3 million during the three months ended March 31, 2023, compared to $90.8 million in the same period in 2022, reflecting improved working capital management[123] - Capital expenditures totaled $23.2 million for the three months ended March 31, 2023, compared to $19.2 million in the same period in 2022[124] Debt and Share Repurchase - As of March 31, 2023, total debt amounted to $2.12 billion, with approximately $595.1 million of additional borrowings available under the Credit Agreement[129] - The company has $3.2 billion of remaining availability for its share repurchase program as of March 31, 2023, with $250.0 million spent on repurchases during the three months ended March 31, 2023[135] Other Considerations - The company expects the financial impact of the Inflation Reduction Act to be immaterial to its financial statements[127] - A 1% strengthening of the Swiss franc against the euro is estimated to reduce earnings before tax by approximately $1.9 million to $2.1 million annually[137] - The company continues to explore potential acquisitions, which may incur additional indebtedness[126] Regional Performance - Chinese Operations reported a 6% decline in total net sales to $246.2 million, with segment profit decreasing by 4% to $81.2 million for the three months ended March 31, 2023[116]

Safe Harbor Statement Summary Comments – Q1 2023 + 7% + 10% Q1 Highlights Sales by Geography Q1 Local Currency Sales Growth Note: Local currency (LC) sales excludes foreign exchange impact. Sales by Product Area 5 Q1 Local Currency Sales Growth Lab (56% of total sales) Industrial (38%) Food Retail (6%) Total (100%) 18% 12% -14% 14% 5% 7% 36% 7% 2022 2023 Note: Local currency (LC) sales excludes foreign exchange impact. Earnings Webcast May 5, 2023 Statements in this presentation which are not historical fac ...

Mettler-Toledo International Inc. (NYSE:MTD) Q4 2022 Earnings Conference Call February 10, 2023 8:30 AM ET Company Participants Patrick Kaltenbach - President, Chief Executive Officer Shawn Vadala - Chief Financial Officer Adam Uhlman - Head of Investor Relations Conference Call Participants Josh Waldman - Cleveland Research Dan Arias - Stifel Jack Meehan - Nephron Research Vijay Kumar - Evercore ISI Tim Daley - Wells Fargo Matt Sykes - Goldman Sachs Brandon Couillard - Jefferies Catherine Schulte - Baird ...

Tax and Valuation - As of December 31, 2022, the company reported a valuation allowance of $62.6 million for deferred tax assets based on estimates of future taxable income [263]. - The company plans to repatriate earnings from multiple countries, expecting additional tax costs related to non-U.S. withholding taxes and U.S. taxes on currency gains [264]. - The company’s earnings before taxes for the year ended December 31, 2022, were $1.1 billion, with each increase of $10.7 million in tax expense raising the effective tax rate by 1% [265]. Pension and Benefit Plans - The net periodic pension cost for the U.S. pension plan was $0.5 million, with a projected benefit obligation of $110.3 million as of December 31, 2022 [266]. - A change in the discount rate of 1% would impact annual benefit plan expense by approximately $10.8 million after tax [269]. - The weighted average return on assets assumption was 6.75% for the U.S. pension plan and 3.84% for international plans in 2022 [268]. Goodwill and Intangible Assets - The company’s consolidated balance sheet included goodwill of $660.2 million and other intangible assets of $306.1 million as of December 31, 2022 [270]. - The company evaluates goodwill and indefinite-lived intangible assets annually for impairment, with no impairments reported to date [274]. Financial Instruments - The fair value of cross currency swap agreements was a net asset of $4.1 million at December 31, 2022, with a potential change of approximately $4.5 million from a 100-basis-point change in interest rates [260]. - The company has limited involvement with derivative financial instruments and does not use them for trading purposes [259].

Mettler-Toledo International Inc. (NYSE:MTD) Q3 2022 Earnings Conference Call November 3, 2022 5:00 PM ET Company Participants Adam Uhlman - Investor Relations Patrick Kaltenbach - Chief Executive Officer Shawn Vadala - Chief Financial Officer Mary Finnegan - Investor Relations Conference Call Participants Josh Waldman - Cleveland Research Jordan Adler - Evercore ISI Tim Daley - Wells Fargo Alonso Garcia - UBS Matt Sykes - Goldman Sachs Operator Good afternoon. My name is Audra, and I will be your conferenc ...